• Mashup Score: 14

    The Connective Tissue Oncology Society is a non-profit professional medical organization whose members are a multidisciplinary group of specialized physicians, medical professionals, and scientists from around the world to connect, and share their knowledge, experiences, and research for the advancement of treatment of sarcomas. If you are interested in becoming a member and serving on a…

    Tweet Tweets with this article
    • RT @GladdyLab: Abstract submission is open #ctos2023 Nov 1-4 2023 in Dublin,🇮🇪 https://t.co/yRqhXwpK38 Sarcoma of the Year #SRBC Keynote…

  • Mashup Score: 5

    October 2022 Oncology Imaging: Updates and Advancements Edited by Natalie S. Lui Imaging is at the core of surgical oncology. Longstanding techniques, such as computed tomography and MRI, as well as nuclear medicine methods, such as PET, have been studied and refined over the years. They form the basis of preoperative staging and complex surgical planning. For a long time, surgeons relied on…

    Tweet Tweets with this article
    • RT @SurgicalClinics: Our latest #SurgOnc Clinics #Podcast is up! @ https://t.co/kzHsXPMBa2 Editors @alegronchi @IstTumori + @chandrajitraut…

  • Mashup Score: 6

    August 2022 A Surgeon’s Guide to Sarcomas and Other Soft Tissue Tumors Edited by John M. Kane Surgeons are frequently referred patients for the evaluation of a soft tissue mass. Given that “common things occur commonly,” the majority will be benign entities such as a lipoma, epidermal inclusion cyst, hematoma, abscess, ganglion cyst, and such. Surgical excision is often the definitive treatment….

    Tweet Tweets with this article
    • RT @SurgicalClinics: Aug 2022 @SurgicalClinics NOW ONLINE! 12 articles on #Sarcoma @ https://t.co/0U05GPKbNY Series also on @ScienceDirect…

  • Mashup Score: 6

    Antitumor T cell responses are the primary mediators of cancer immunotherapy. However, many other components of the immune system are needed for efficient T cell responses to be generated. Here, we developed a combinatorial approach where a Toll-like receptor 9 agonist (CpG) and Fc-fused IL-12 prote …

    Tweet Tweets with this article
    • RT @Chrystal_Paulos: Intratumoral immunotherapy relies on B and T cell collaboration - PubMed https://t.co/DZZxAO7PGQ

  • Mashup Score: 11

    Immune-checkpoint inhibitors (ICIs) have dramatically improved the outcomes of patients with advanced-stage solid tumours, including the potential for long-term remission in a subset. However, long-term follow-up data reveal a risk of chronic toxicities from these agents, which can have important quality-of-life implications. In this Review, the authors describe the current level of evidence of…

    Tweet Tweets with this article
    • RT @BrianGastmanMD: https://t.co/xdVQg4TYML. Long term irAEs are not talked about enough. We are bringing these therapies to earlier dise…